{"id":5798,"date":"2026-04-29T13:45:21","date_gmt":"2026-04-29T13:45:21","guid":{"rendered":"https:\/\/pharmanomos.ch\/?p=5798"},"modified":"2026-04-29T13:45:21","modified_gmt":"2026-04-29T13:45:21","slug":"parallel-import-of-drugs-into-switzerland-what-does-the-law-say","status":"publish","type":"post","link":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/","title":{"rendered":"Parallel import of drugs into Switzerland: what does the law say?"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">Parallel importation of medicines is an issue of great interest to pharmaceutical stakeholders, particularly importers, distributors, and pharmacies operating in an increasingly competitive and regulated environment.<\/p>\n\n<p class=\"has-medium-font-size\">In Switzerland, this practice is permitted but subject to strict requirements set by Swissmedic and the federal regulatory framework. Understanding what is actually allowed and what the critical issues are is essential to avoid regulatory risks and ensure patient safety. <\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">What is parallel importation of drugs<\/h2>\n\n<p class=\"has-medium-font-size\">Parallel importation is the introduction of a medicine already authorized in another country into the Swiss market without the direct consent of the original authorization holder.<\/p>\n\n<p class=\"has-medium-font-size\">This practice is based on the principle of free movement of goods, but in the pharmaceutical sector it is severely limited by safety, quality and efficacy requirements.<\/p>\n\n<p class=\"has-medium-font-size\">In other words, this is not just a commercial activity: each product must meet standards equivalent to those required for medicines authorized in Switzerland.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">The Swiss regulatory framework<\/h2>\n\n<p class=\"has-medium-font-size\">In Switzerland, parallel import is mainly regulated by:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>the Therapeutic Agents Act (LATer)<\/li>\n\n\n\n<li>related ordinances<\/li>\n\n\n\n<li>The guidelines and requirements established by Swissmedic<\/li>\n<\/ul>\n\n<p class=\"link-verde has-medium-font-size\">A general overview of the Swiss regulatory system can be found on Swissmedic&#8217;s official website:<br\/><a href=\"https:\/\/www.swissmedic.ch\">https:\/\/www.swissmedic.ch<\/a><\/p>\n\n<p class=\"link-verde has-medium-font-size\">The normative reference text (LATer) is available on the federal portal:<br\/><a href=\"https:\/\/www.fedlex.admin.ch\">https:\/\/www.fedlex.admin.ch<\/a><\/p>\n\n<p class=\"has-medium-font-size\">Unlike the European Union, where there is a more structured and harmonized system, Switzerland takes a more restrictive approach.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Mandatory authorization<\/h3>\n\n<p class=\"has-medium-font-size\">Those wishing to carry out parallel import must obtain specific authorization from Swissmedic.<\/p>\n\n<p class=\"has-medium-font-size\">The key requirement is to demonstrate that the imported medicine is <strong>identical or essentially equivalent<\/strong> to a product already authorized in Switzerland.<\/p>\n\n<div class=\"wp-block-uagb-info-box uagb-block-3966eb25 uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin link-verde\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h3 class=\"uagb-ifb-title\">Parallel import: are you really complying with Swissmedic requirements?<\/h3><\/div><div class=\"uagb-ifb-separator\"><\/div><p class=\"uagb-ifb-desc\">Many companies underestimate the complexity of parallel importation into Switzerland, exposing themselves to avoidable regulatory risks.<br\/>The most frequent critical issues include:<br\/><br\/>Incomplete assessment of drug equivalence<br\/>Documentation that does not comply with Swissmedic&#8217;s requirements<br\/>Quality system not adequate for import management<br\/><br\/>A targeted audit allows for quick identification of any gaps and defining an effective compliance pathway.<br\/><br\/><strong>Request an audit<\/strong><\/p><div class=\"uagb-ifb-button-wrapper wp-block-button\"><a href=\"https:\/\/pharmanomos.ch\/en\/contact\/\" class=\"uagb-infobox-cta-link wp-block-button__link\" target=\"_blank\" rel=\"noopener noreferrer\" onclick=\"return true;\"><span class=\"uagb-inline-editing\">Check your regulatory compliance<\/span><\/a><\/div><\/div><\/div><\/div>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Parallel import requirements<\/h2>\n\n<p class=\"has-medium-font-size\">In order to operate legally, importers must meet several basic requirements.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">1. Equivalence of the drug<\/h3>\n\n<p class=\"has-medium-font-size\">The imported product must have:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>the same active ingredient<\/li>\n\n\n\n<li>the same pharmaceutical form<\/li>\n\n\n\n<li>the same dosage<\/li>\n\n\n\n<li>An equivalent qualitative and quantitative composition<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">Even minor differences can lead to rejection of the request.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">2. Quality and safety<\/h3>\n\n<p class=\"has-medium-font-size\">It is necessary to ensure that the medicine:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>Is produced in accordance with Good Manufacturing Practices (GMP)<\/li>\n\n\n\n<li>Maintain the same quality as the product authorized in Switzerland<\/li>\n\n\n\n<li>Is traceable throughout the supply chain<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">3. Labeling and information<\/h3>\n\n<p class=\"has-medium-font-size\">Therefore, the product must be adapted to the Swiss market:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>labeling in accordance with official languages<\/li>\n\n\n\n<li>approved package insert<\/li>\n\n\n\n<li>Information consistent with the authorized file<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">4. Import authorization<\/h3>\n\n<p class=\"has-medium-font-size\">The operator must possess:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>import authorization<\/li>\n\n\n\n<li>adequate quality system<\/li>\n\n\n\n<li>qualified responsible person<\/li>\n<\/ul>\n\n<p class=\"link-verde has-medium-font-size\">For more information on permits and activities subject to inspection, please see:<br\/><a href=\"https:\/\/www.swissmedic.ch\">https:\/\/www.swissmedic.ch<\/a><\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">The main critical regulatory issues<\/h2>\n\n<p class=\"has-medium-font-size\">Despite the theoretical possibility, parallel import into Switzerland has several operational criticalities.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Authorization complexity<\/h3>\n\n<p class=\"has-medium-font-size\">The approval process can be lengthy and requires detailed documentation. The assessment of equivalence is not always straightforward and can vary on a case-by-case basis. <\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Differences from the EU<\/h3>\n\n<p class=\"has-medium-font-size\">Many practitioners make the mistake of applying European logic to the Swiss context.<\/p>\n\n<p class=\"has-medium-font-size\">Actually:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>there is no automatic mutual recognition<\/li>\n\n\n\n<li>Swissmedic conducts an independent assessment<\/li>\n\n\n\n<li>requirements may be more stringent<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Risks of non-compliance<\/h3>\n\n<p class=\"has-medium-font-size\">Errors in parallel import management can result in:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>regulatory sanctions<\/li>\n\n\n\n<li>withdrawal of products from the market<\/li>\n\n\n\n<li>reputational damage<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Supply chain management<\/h3>\n\n<p class=\"has-medium-font-size\">Ensuring traceability and quality throughout the distribution chain is particularly complex, especially when products come from different markets.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">When does it really pay off?<\/h2>\n\n<p class=\"has-medium-font-size\">Parallel import can represent an opportunity in terms of:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>cost reduction<\/li>\n\n\n\n<li>increased competitiveness<\/li>\n\n\n\n<li>access to certain products<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">However, it is sustainable only if:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>volume justifies regulatory costs<\/li>\n\n\n\n<li>there is an appropriate organizational structure<\/li>\n\n\n\n<li>regulatory risk is under control<\/li>\n<\/ul>\n\n<div class=\"wp-block-uagb-info-box uagb-block-77c0e0db uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin link-verde\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h3 class=\"uagb-ifb-title\">Do you want to import drugs into Switzerland without risk?<\/h3><\/div><div class=\"uagb-ifb-separator\"><\/div><p class=\"uagb-ifb-desc\">Parallel importation can be a real opportunity, but only if it is managed with a structured and compliant approach.<br\/><br\/>Pharmanomos Sagl supports importers, distributors, and pharmacies at all stages:<br\/><br\/>Regulatory feasibility assessment<br\/>Dossier preparation and review<br\/>Quality system implementation<br\/>Support during interactions with Swissmedic<br\/><br\/><strong>Relying on specialists means reducing time, costs, and risks.<\/strong><\/p><div class=\"uagb-ifb-button-wrapper wp-block-button\"><a href=\"https:\/\/pharmanomos.ch\/en\/contact\/\" class=\"uagb-infobox-cta-link wp-block-button__link\" target=\"_blank\" rel=\"noopener noreferrer\" onclick=\"return true;\"><span class=\"uagb-inline-editing\">Request a personalized consultation<\/span><\/a><\/div><\/div><\/div><\/div>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Conclusion<\/h2>\n\n<p class=\"has-medium-font-size\">Parallel import of drugs into Switzerland is a real possibility, but not without its complexities.<\/p>\n\n<p class=\"has-medium-font-size\">Operating in this field requires:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>A deep understanding of the regulatory framework<\/li>\n\n\n\n<li>strict quality management<\/li>\n\n\n\n<li>a well-defined strategy<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">Only a structured approach can turn this opportunity into a real competitive advantage, avoiding risk and ensuring patient safety.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parallel importation of medicines is an issue of great interest to pharmaceutical stakeholders, particularly importers, distributors, and pharmacies operating in an increasingly competitive and regulated environment. In Switzerland, this practice is permitted but subject to strict requirements set by Swissmedic and the federal regulatory framework. Understanding what is actually allowed and what the critical issues [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5799,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-senza-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Parallel import of drugs into Switzerland: Regulations and Requirements<\/title>\n<meta name=\"description\" content=\"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Parallel import of drugs into Switzerland: Regulations and Requirements\" \/>\n<meta property=\"og:description\" content=\"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T13:45:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1448\" \/>\n\t<meta property=\"og:image:height\" content=\"1086\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"giuseppe.cantoni.marketer@gmail.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"giuseppe.cantoni.marketer@gmail.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/\"},\"author\":{\"name\":\"giuseppe.cantoni.marketer@gmail.com\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/person\\\/63997ce71a35d3b996aaa2af93f1fa71\"},\"headline\":\"Parallel import of drugs into Switzerland: what does the law say?\",\"datePublished\":\"2026-04-29T13:45:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/\"},\"wordCount\":776,\"publisher\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp\",\"articleSection\":[\"Senza categoria\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/\",\"name\":\"Parallel import of drugs into Switzerland: Regulations and Requirements\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp\",\"datePublished\":\"2026-04-29T13:45:21+00:00\",\"description\":\"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp\",\"contentUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp\",\"width\":1448,\"height\":1086,\"caption\":\"Modern pharmaceutical warehouse environment with drug packages on distribution line, representation of supply chain and drug import in Switzerland\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Parallel import of drugs into Switzerland: what does the law say?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\",\"name\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\",\"description\":\"Soluzioni su misura per la gestione della qualit\u00e0 nelle farmacie. Consulenza specializzata, documentazione digitale e area clienti riservata.\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\",\"name\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-Logo-Pharmanomos-1-1.png\",\"contentUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-Logo-Pharmanomos-1-1.png\",\"width\":766,\"height\":300,\"caption\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pharmanomos-sagl\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/person\\\/63997ce71a35d3b996aaa2af93f1fa71\",\"name\":\"giuseppe.cantoni.marketer@gmail.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"caption\":\"giuseppe.cantoni.marketer@gmail.com\"},\"sameAs\":[\"https:\\\/\\\/pharmanomos.ch\"],\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/author\\\/giuseppe-cantoni-marketergmail-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Parallel import of drugs into Switzerland: Regulations and Requirements","description":"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/","og_locale":"en_US","og_type":"article","og_title":"Parallel import of drugs into Switzerland: Regulations and Requirements","og_description":"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.","og_url":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/","og_site_name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","article_published_time":"2026-04-29T13:45:21+00:00","og_image":[{"width":1448,"height":1086,"url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp","type":"image\/webp"}],"author":"giuseppe.cantoni.marketer@gmail.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"giuseppe.cantoni.marketer@gmail.com","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#article","isPartOf":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/"},"author":{"name":"giuseppe.cantoni.marketer@gmail.com","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/person\/63997ce71a35d3b996aaa2af93f1fa71"},"headline":"Parallel import of drugs into Switzerland: what does the law say?","datePublished":"2026-04-29T13:45:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/"},"wordCount":776,"publisher":{"@id":"https:\/\/pharmanomos.ch\/en\/#organization"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp","articleSection":["Senza categoria"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/","url":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/","name":"Parallel import of drugs into Switzerland: Regulations and Requirements","isPartOf":{"@id":"https:\/\/pharmanomos.ch\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#primaryimage"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp","datePublished":"2026-04-29T13:45:21+00:00","description":"Learn how the parallel import of drugs into Switzerland works: requirements, Swissmedic approvals, and key regulatory concerns.","breadcrumb":{"@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#primaryimage","url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp","contentUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp","width":1448,"height":1086,"caption":"Modern pharmaceutical warehouse environment with drug packages on distribution line, representation of supply chain and drug import in Switzerland"},{"@type":"BreadcrumbList","@id":"https:\/\/pharmanomos.ch\/en\/parallel-import-of-drugs-into-switzerland-what-does-the-law-say\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmanomos.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Parallel import of drugs into Switzerland: what does the law say?"}]},{"@type":"WebSite","@id":"https:\/\/pharmanomos.ch\/en\/#website","url":"https:\/\/pharmanomos.ch\/en\/","name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","description":"Soluzioni su misura per la gestione della qualit\u00e0 nelle farmacie. Consulenza specializzata, documentazione digitale e area clienti riservata.","publisher":{"@id":"https:\/\/pharmanomos.ch\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmanomos.ch\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharmanomos.ch\/en\/#organization","name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","url":"https:\/\/pharmanomos.ch\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/logo\/image\/","url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2025\/05\/cropped-Logo-Pharmanomos-1-1.png","contentUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2025\/05\/cropped-Logo-Pharmanomos-1-1.png","width":766,"height":300,"caption":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/pharmanomos-sagl\/"]},{"@type":"Person","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/person\/63997ce71a35d3b996aaa2af93f1fa71","name":"giuseppe.cantoni.marketer@gmail.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","caption":"giuseppe.cantoni.marketer@gmail.com"},"sameAs":["https:\/\/pharmanomos.ch"],"url":"https:\/\/pharmanomos.ch\/en\/author\/giuseppe-cantoni-marketergmail-com\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp",1448,1086,false],"thumbnail":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali-150x150.webp",150,150,true],"medium":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali-300x225.webp",300,225,true],"medium_large":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali-768x576.webp",768,576,true],"large":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali-1024x768.webp",1024,768,true],"1536x1536":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp",1448,1086,false],"2048x2048":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/04\/Magazzino-farmaceutico-in-Svizzera-e-gestione-della-supply-chain-dei-medicinali.webp",1448,1086,false]},"uagb_author_info":{"display_name":"giuseppe.cantoni.marketer@gmail.com","author_link":"https:\/\/pharmanomos.ch\/en\/author\/giuseppe-cantoni-marketergmail-com\/"},"uagb_comment_info":0,"uagb_excerpt":"Parallel importation of medicines is an issue of great interest to pharmaceutical stakeholders, particularly importers, distributors, and pharmacies operating in an increasingly competitive and regulated environment. In Switzerland, this practice is permitted but subject to strict requirements set by Swissmedic and the federal regulatory framework. Understanding what is actually allowed and what the critical issues&hellip;","_links":{"self":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/comments?post=5798"}],"version-history":[{"count":2,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5798\/revisions"}],"predecessor-version":[{"id":5805,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5798\/revisions\/5805"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/media\/5799"}],"wp:attachment":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/media?parent=5798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/categories?post=5798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/tags?post=5798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}